The Valley Desk

ArticleTherapeutic advances in musculoskeletal diseasePublished

Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Therapeutic advances in musculoskeletal disease
Published
Subject terms
Rheumatoid arthritis; Programmed Cell Death Protein 1
PubMed ID
41146691
PubMed Central ID
PMC12553887
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal